ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

Forgot password
  • Home
  • About
  • News
  • FDA Advisory Committee recommends Isavuconazonium (Cresemba) for approval

FDA Advisory Committee recommends Isavuconazonium (Cresemba) for approval

13 Feb 2015 4:51 PM | Kristi Kuper

An advisory committee to the US Food and Drug Administration (FDA) voted unanimously to recommend isavuconazonium (ISA) (Cresemba, Astellas Pharma, Inc) for the treatment of adults with invasive aspergillosis (IA) and voted (8 yes, 2 no, 1 abstain) to recommend the drug for the treatment of adults with invasive mucormycosis (IM).http://www.medscape.com/viewarticle/838620



Society of Infectious Diseases Pharmacists •  PO Box 1488, Warrenville, IL 60555
(331) 248-7888 • sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software